Search tips
Search criteria 


Logo of jurbhealthspringer.comThis journalToc AlertsSubmit OnlineOpen ChoiceThis journal
J Urban Health. 2003 June; 80(2): 220–229.
PMCID: PMC3456269

The relationship between depressive symptoms and nonfatal overdose among a sample of drug users in Baltimore, Maryland


Nonfatal drug overdoses are common among heroin users. While several factors that increase risk of overdose have been identified, there is little research on the role of mental health status. The purpose of this study was to examine the association between depressive symptoms and history of overdose. A sample of 729 opiate and cocaine users completed a cross-sectional survey. Of the sample, 65% reported never having overdosed, 31% had overdosed longer than 12 months before the interview, and 4% had overdosed within the past 12 months. Results indicate that a high score on the Center for Epidemiological Studies Depression Scale (CES-D), a measure of depressive symptoms, was associated with having overdosed within the past 12 months (relative risk ratio [RRR]=3.06; 95% confidence interval [CI], 1.33 to 7.05) after adjusting for age, gender, injection frequency, and physical health impairment. These results suggest that drug users with depressive symptoms should be targeted for overdose prevention programs.

Full Text

The Full Text of this article is available as a PDF (75K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Sporer KA. Acute heroin overdose. Ann Intern Med. 1999;130:584–590. [PubMed]
2. Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: II. responses to overdose. Addiction. 1996;91:413–417. doi: 10.1111/j.1360-0443.1996.tb02290.x. [PubMed] [Cross Ref]
3. White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction. 1999;94:961–972. doi: 10.1046/j.1360-0443.1999.9479612.x. [PubMed] [Cross Ref]
4. Warner-Smith M, Darke S, Day C. Morbidity associated with non-fatal heroin overdose. Addiction. 2002;97:963–967. doi: 10.1046/j.1360-0443.2002.00132.x. [PubMed] [Cross Ref]
5. Olfson M, Shea S, Feder A, et al. Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice. Arch Fam Med. 2000;9:876–883. doi: 10.1001/archfami.9.9.876. [PubMed] [Cross Ref]
6. Borges G, Walters EE, Kessler RC. Associations of substance use, abuse, and dependence with subsequent suicidal behavior. Am J Epidemiol. 2000;151:781–789. [PubMed]
7. Bronisch T, Wittchen HU. Suicidal ideation and suicide attempts: comorbidity with depression, anxiety disorders, and substance abuse disorder. Eur Arch Psychiatry Clin Neurosci. 1994;244:93–98. doi: 10.1007/BF02193525. [PubMed] [Cross Ref]
8. Oppenheimer E, Tobutt C, Taylor C, Andrew T. Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. Addiction. 1994;89:1299–1308. doi: 10.1111/j.1360-0443.1994.tb03309.x. [PubMed] [Cross Ref]
9. Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001;58:503–508. doi: 10.1001/archpsyc.58.5.503. [PubMed] [Cross Ref]
10. Darke S, Ross J. The relationship between suicide and heroin overdose among methadone maintenance patients in Sydney, Australia. Addiction. 2001;96:1443–1453. doi: 10.1046/j.1360-0443.2001.961014438.x. [PubMed] [Cross Ref]
11. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry. 1985;142:1259–1264. [PubMed]
12. Weiss RD, Griffin ML, Mirin SM. Drug abuse as self-medication for depression: an empirical study. Am J Drug Alcohol Abuse. 1992;18:121–129. [PubMed]
13. Zador D, Sunjic S, McLennan J. Circumstances and users’ perceptions of heroin overdose at the time of the event and at 1-week follow-up in Sydney, Australia: implications for prevention. Addict Res Theory. 2001;9:407–423.
14. Latkin CA, Forman VL. Patterns of needle acquisition and sociobehavioral correlates of needle exchange program attendance in Baltimore, Maryland, USA. J Acquir Immune Defic Syndr. 2001;27:398–404. [PubMed]
15. Radloff L. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.
16. Radloff L, Locke B. The community mental health assessment survey and the CES-D Scale. In: Weissman M, Myers J, Roass C, editors. Community Surveys of Psychiatric Disorder. New Brunswick, NJ: Rutgers University Press; 1986. pp. 177–189.
17. Zimmerman M, Coryell W. The validity of a self-report questionnaire for diagnosing major depressive disorder. Arch Gen Psychiatry. 1988;45:738–740. [PubMed]
18. Knowlton AR, Latkin CA, Schroeder JR, Hoover DR, Ensminger M, Celentano DD. Longitudinal predictors of depressive symptoms among low income injection drug users. AIDS Care. 2001;13:549–559. doi: 10.1080/09540120120063197. [PubMed] [Cross Ref]
19. Boyd JH, Weissman MM, Thompson WD, Myers JK. Screening for depression in a community sample. Understanding the discrepancies between depression symptom and diagnostic sales. Arch Gen Psychiatry. 1982;39:1195–1200. [PubMed]
20. Ware J. The status of health assessment. Annu Rev Public Health. 1995;16:327–354. doi: 10.1146/annurev.pu.16.050195.001551. [PubMed] [Cross Ref]
21. Akaike H. A new look at statistical model identification. IEEE Trans Automatic Control. 1974;19:716–722. doi: 10.1109/TAC.1974.1100705. [Cross Ref]
22. Stata [computer software]. Version 6. College Station, TX: Stata; 1999.
23. Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: I. prevalence and correlates of non-fatal overdose. Addiction. 1996;91:405–411. doi: 10.1111/j.1360-0443.1996.tb02289.x. [PubMed] [Cross Ref]
24. Darke S, Zador D. Fatal heroin “overdose”,: a review. Addiction. 1996;91:1765–1772. doi: 10.1111/j.1360-0443.1996.tb03800.x. [PubMed] [Cross Ref]
25. Davoli M, Perucci CA, Forastiere F, et al. Risk factors for overdose mortality: a casecontrol study within a cohort of intravenous drug users. Int J Epidemiol. 1993;22:273–277. [PubMed]
26. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry. 1985;142:1259–1264. [PubMed]
27. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19. [PubMed]
28. Grant BF. Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. J Subst Abuse. 1995;74:481–497. doi: 10.1016/0899-3289(95)90017-9. [PubMed] [Cross Ref]
29. Kandel DB, Huang FY, Davies M. Comorbidity between patterns of substance use dependence and psychiatric syndromes. Drug Alcohol Depend. 2001;64:233–241. doi: 10.1016/S0376-8716(01)00126-0. [PubMed] [Cross Ref]
30. Brooner RK, King VL, Kidorf M, Schmidt CW, Jr, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 1997;54:71–80. [PubMed]
31. Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber C, Kleber H. Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome. Arch Gen Psychiatry. 1982;39:151–156. [PubMed]
32. Dinwiddie SH, Cottler L, Compton W, Abdallah AB. Psychopathology and HIV risk behaviors among injection drug users in and out of treatment. Drug Alcohol Depend. 1996;43:1–11. doi: 10.1016/S0376-8716(96)01290-2. [PubMed] [Cross Ref]
33. Jones R, Gruer L, Gilchrist G, Seymour A, Black M, Oliver J. Recent contact with health and social services by drug misusers in Glasgow’who died of a fatal overdose in 1999. Addiction. 2002;97:1517–1522. doi: 10.1046/j.1360-0443.2002.00244.x. [PubMed] [Cross Ref]

Articles from Journal of Urban Health : Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine